Trial
NCT01484314
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
—
Condition
Thrombocytopenia
Intervention
Eltrombopag
Why stopped
Low accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-15